Sign In
Buy GHSI
$3.22
+0 (+0%)
At Close: Sep 18, 2025
The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates
02:36pm, Wednesday, 26'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 25) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) (Cowen
24 Healthcare Stocks Moving In Wednesday's Pre-Market Session
01:01pm, Wednesday, 26'th Feb 2020
Gainers
Tonix Pharmaceuticals, Inc. (NASDAQ: TNXP) stock moved upwards by 65.7% to $0.67 during Wednesday's pre-market session.
InflaRx, Inc. (NASDAQ: IFRX) stock...
Guardion Health Sciences Selected by Malaysian Listed Company to Develop an Immuno-Supportive Formula
12:00pm, Wednesday, 26'th Feb 2020
Guardion® has signed a Letter of Appointment with Ho Wah Genting Berhad (HWGB) to create a new formula, designed to enhance the immune system. San Diego, California, Feb. 26, 2020 (GLOBE NEWSWIRE
Guardion® Announces Development of Unique Immuno-Supportive Complex Targeting Upper Respiratory Tract Infections
12:00pm, Thursday, 06'th Feb 2020
Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (GHSI) announced the development of a unique proprietary formulation to provide immuno-support and anti-inflammatory benefits targe
Guardion® Appoints Experienced Executive to Lead Development and Expansion of Recently-Acquired NutriGuard Business Line
04:02pm, Tuesday, 07'th Jan 2020
Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (GHSI), a leader in the field of ocular health technologies and products, announced that it has hired John P. Troup, PhD to serve a
KNUST distance learning masters programmes 2020
09:20am, Friday, 20'th Dec 2019
⭐KNUST DISTANCE LEARNING⭐: knowing which masters programmes are available will help any student aspiring to take a course at the school plan.
Guardion Health Sciences, Inc. Reports Results for the Three and Nine Months Ended September 30, 2019
12:00pm, Thursday, 14'th Nov 2019
Results Highlighted by 33% Increase in Revenues for Guardion’s Flagship Medical Food Lumega-Z® San Diego, CA, Nov. 14, 2019 -- Guardion Health Sciences, Inc. (“Guardion” or.
Guardion Health Sciences Closes $8.4 Million Underwritten Public Offering
04:33pm, Wednesday, 30'th Oct 2019
Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (GHSI), today announced the closing of its previously announced underwritten public offering of 24,500,000 shares of its common sto
Guardion Health Sciences Announces Pricing of $8.4 Million Underwritten Public Offering
01:21pm, Monday, 28'th Oct 2019
Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (GHSI), announced the pricing of an underwritten public offering of 24,500,000 shares of its common stock (or pre-funded warrants t
Guardion® Receives approval from USPTO for expanded claims for its Proprietary Medical Device, the MAPCAT SF
11:00am, Wednesday, 23'rd Oct 2019
Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (GHSI) announced that it has received approval from the USPTO for additional claims reflected in a new patent for its proprietary m
Here's Why We're A Bit Worried About Guardion Health Sciences's (NASDAQ:GHSI) Cash Burn Situation
02:40pm, Thursday, 17'th Oct 2019
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Guardion® Announces Statistically Significant Blood Assay Study Results
02:30pm, Thursday, 10'th Oct 2019
Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (GHSI) announced the formal results of a blood assay study that established that Lumega-Z, Guardion’s proprietary medical food de
Guardion Health Sciences Acquires the NutriGuard Brand of Products
02:30pm, Monday, 23'rd Sep 2019
Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (GHSI), through its newly-formed wholly-owned subsidiary, NutriGuard Formulations, Inc., has acquired certain assets of NutriGuard
Best & worst performing IPOs in 2019
06:08pm, Tuesday, 03'rd Sep 2019
Barron's is breaking down the best and worst IPOs of 2019, with Beyond Meat, Turning Point Therapeutics, CrowdStrike Holdings, and Zoom Video Communications sitting at the top. Yahoo Finance's Zack Gu
Guardion Launches VectorVision CSV-2000 Standardized Contrast Sensitivity Test
11:00am, Tuesday, 03'rd Sep 2019
Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (GHSI) announced that it has completed development of its proprietary CSV-2000 standardized contrast sensitivity test and will intr
